vimarsana.com

Page 72 - அமெரிக்கன் கலைக்கழகம் ஆஃப் நரம்பியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Medicare paid 50% more for neurology drugs over 5 years while claims rose only 8%

 E-Mail MINNEAPOLIS - A new study of Medicare payments has found that over a five-year period, the payments for medications prescribed to people with neurologic conditions like multiple sclerosis (MS), Parkinson s disease and epilepsy increased by 50% while the number of claims for these prescription medications only rose by only 8%. The study is published in the March 10, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study, funded by the American Academy of Neurology, also found that most of the increase was due to rising costs for neuroimmunology drugs, mostly for multiple sclerosis. Previous research has shown that drugs prescribed for neurologic disease are the most expensive part of neurologic care for people on Medicare, said study author Adam de Havenon, MD, of the University of Utah, Salt Lake City, and a member of the American Academy of Neurology. Our study shows a dramatic increase in the prices of neurologic medic

Risk of rebound headaches increases in people using cannabis for migraine treatment

Risk of rebound headaches increases in people using cannabis for migraine treatment ANI | Updated: Mar 07, 2021 19:36 IST Washington [US], March 7 (ANI): Researchers during a recent study found that individuals, who use cannabis for relief from migraine, might later develop rebound headaches. This would be similar to headaches that people who overuse migraine pain medication experience. The preliminary study released on March 1 and will be presented at the American Academy of Neurology s 73rd Annual Meeting being held virtually from April 17 to 22, 2021. Many people with chronic migraine are already self-medicating with cannabis, and there is some evidence that cannabis can help treat other types of chronic pain, said study author Niushen Zhang, M.D., of Stanford University School of Medicine in Stanford, California, and a member of the American Academy of Neurology.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.